Pubblicazioni

Pubblicazioni

1) Synthesis, antioxidant and antimicrobial activity of a new phloridzin derivative for dermo-cosmetic applications. Baldisserotto A, Malisardi G, Scalambra E, Andreotti E, Romagnoli C, Vicentini CB, Manfredini S, Vertuani S. Molecules 2012, 17: 13275-89

2) Synthesis and in vitro stability of nucleoside 5'-phosphonate derivatives. Vertuani S, Baldisserotto A, Varani K, Borea PA, De Marcos Maria Cruz B, Ferraro L, Manfredini S, Dalpiaz A. Eur J Med Chem. 2012, 54:202-9.

3) Novel molecular combination deriving from natural aminoacids and polyphenols: Design, synthesis and free-radical scavenging activities. Silvia V, Baldisserotto A, Scalambra E, Malisardi G, Durini E, Manfredini S. Eur J Med Chem. 2012, 50:383-92.

4) Activity and stability studies of verbascoside, a novel antioxidant, in dermo-cosmetic and pharmaceutical topical formulations. Vertuani S, Beghelli E, Scalambra E, Malisardi G, Copetti S, Toso RD, Baldisserotto A, Manfredini S.

Molecules 2011, 16(8) 7068-80

5) Simulated infusion of paclitaxel with in-line filters. Bononi I, Forgetta C, Baldisserotto A, Tognon M. Chemotherapy 2011 57(3) 204-8. Epub 2011 May 9

6) Trypanocidal activity of peptidyl vinyl ester derivatives selective for inhibition of mammalian proteasome trypsin-like activity. Steverding D, Baldisserotto A, Wang X, Marastoni M. Exp Parasitol. 128 (2011) 444–447

7) Proteasome inhibitors induce the presentation of an Epstein–Barr

virus nuclear antigen 1-derived cytotoxic T lymphocyte epitope

in Burkitt’s lymphoma cells. F. Destro, F. Sforza, M. Sicurella, D.

Marescotti, E. Gallerani, A. Baldisserotto, M.Marastoni, R. Gavioli. Immunology,2011, 133, 105–114.

8) Ricerca, sviluppo e valutazione della capacità antiossidante di nuovi estratti di parti aeree di Paeonia per applicazione cosmetica. S. Vertuani, E. Scalambra, E. Durini, A. Baldisserotto , P. Ziosi, S. Manfredini NATURAL 1 2010, vol. settembre; p. 58-67

9) Synthesis and proteasome inhibition of N-allyl vinyl ester-based peptides. Baldisserotto A, Franceschini C, Scalambra F, Trapella C, Marastoni M, Sforza F, Gavioli R, Tomatis R. J Pept Sci. 2010 Nov;16(11):659-63.

10) alpha,beta-Unsaturated N-Acylpyrrole Peptidyl Derivatives: New Proteasome Inhibitors. Baldisserotto A, Ferretti V, Destro F, Franceschini C, Marastoni M, Gavioli R, Tomatis R. J Med Chem. 2010 Sep 9; 53(17): 6511-5.

11) Characterization of an human leucocyte antigen A2-restricted Epstein-Barr virus nuclear antigen-1-derived cytotoxic T-lymphocyte epitope. Marescotti D, Destro F, Baldisserotto A, Marastoni M, Coppotelli G, Masucci M, Gavioli R. Immunology. 2010 Mar;129(3):386-95.

12) N-terminal-prolonged vinyl ester-based peptides as selective proteasome beta1 subunit inhibitors. Baldisserotto A, Destro F, Vertuani G, Marastoni M, Gavioli R, Tomatis R. Bioorg Med Chem. 2009 Aug 1; 17(15): 5535-40.

13) New cyclic peptide proteasome inhibitors. Baldisserotto A, Marastoni M, Gavioli R, Tomatis R. Bioorg Med Chem Lett. 2009 Apr 1;19(7):1966-9.

14) Further studies on lead compounds containing the opiod pharmacophore Dmt-Tic, Balboni G.,  Fiorini S., Baldisserotto A., Trapella C., Sasaki Y., Ambo A., Marczak E.D., Lazarus L.H., Salvatori S. J. Med. Chem. 2008 Aug 28; 51(16): 5109-17.

15) C-terminal constrained phenylalanine as a pharmacophoric unit in peptide-based proteasoma inhibitors, Baldisserotto A., Marastoni M., Lazzari I., Trapella C., Gavioli R., Tomatis R. Eur.  J. Med. Chem. 2008 Jul; 43(7):1403-11.

16) Vinyl ester-based cyclic peptide proteasome inhibitors, Baldisserotto A., Marastoni M., Fiorini S., Pretto L., Ferretti V.,Gavioli R., Tomatis R. Bioorg Med Chem Lett. 2008 Mar 15;18(6):1849-54.

17) In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor, Rizzi A., Spagnolo B., Winford RD., Fischetti C., Guerrini R., Marzola G., Baldisserotto A., Salvatori S., Regoli D., Kapusta DR., Calò G. Peptides. 2007 Jun;28(6):1240-51.

18) Glutamine vynil ester proteasome inhibitors selective for trypsin-like (β2) subunit, Baldisserotto A., Marastoni M., Trapella C., Gavioli R., Ferretti V., Pretto L., Tomatis R. Eur. J. Med. Chem. 2007 May;42(5):586-92.

19) Synthesis and biological evaluation of new vinyl ester pseudotripetide proteasome inhibitors, Marastoni M., Baldisserotto A., Trapella C., Gavioli R.,Tomatis R., Eur. J. Med. Chem. 2006 May 16; 41 (8):978-84.

20) In vitro and in vivo pharmacological characterization of the nociceptin/orphanin FQ receptor ligand Ac-RYYRIK-ol, Gunduz O., Rizzi A., Baldisserotto A., Guerrini R., Spagnolo B.,Gavioli EC., Kocsis L., Magyar A., Benyhe S., Borsodi A.,Calò G., Eur. J.Pharmacol. 2006 Jun 6; 539 (1-2):39-48.

21) P3 and P4 position analysis of vinyl ester pseudopeptide proteasome inhibitors, Marastoni M., Baldisserotto A., Trapella C., Gavioli R., Tomatis R., Bioorg. Med. Chem. Lett. 2006 Jun 15; 16 (12):3125-30.

22) Peptidyl vinyl ester derivatives: new class of selective inhibitors of proteasome trypsin-like activity, Marastoni M., Baldisserotto A., Cellini S., Gavioli R., Tomatis R., J. Med. Chem. 2005 Jul 28; 48 (15):5038-42.

23) Hiv Protease Inhibitors: Synthesis and Activity of N-Aryl-N’-hydroxyalkyl hydrazide Pseudopeptides, Marastoni M., Baldisserotto A., Trapella C., McDonald J.,Bortolotti F., Tomatis R., Eur. J. Med. Chem. 2005 May; 40 (5):445-51.

24) Proteasome inhibitors: synthesis and activity of arecoline oxide tripeptide derivatives, Marastoni M.,Mc Donald J.,Baldisserotto A.,Canella A.,Risi CD.,Pollini GP,Tomatis R., Bioorg. Med. Chem. Lett. 2004 Apr 19; 14 (8):1965-8.

25) Arecoline tripeptide inhibitors of proteasome, Marastoni M.,Baldisserotto A.,Canella A.,Gavioli R.,Risi CD.,Pollini GP,Tomatis R., J. Med. Chem. 2004 Mar 11; 47 (6):1587-90.